Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2013
07/18/2013US20130183681 Device and method of monitoring a patient
07/18/2013US20130183680 Assays and methods for the diagnosis of post-streptococcal disorders
07/18/2013US20130183673 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias
07/18/2013US20130183665 Synthesis of fluorescent noble metal nanoparticles
07/18/2013US20130183662 Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations
07/18/2013US20130183660 Apparatus for Disease Detection
07/18/2013US20130183658 Methods and Devices for Rapid Detection of Live Microorganisms by Aptamers and/or Antibodies Immobilized on Permeable Membranes
07/18/2013US20130183399 Method for Improving Physical Performance During Physical Exertion
07/18/2013US20130183326 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
07/18/2013US20130183319 Fgfr4 antibodies
07/18/2013US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells
07/18/2013US20130183317 G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
07/18/2013US20130183313 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists
07/18/2013US20130183304 Neuropilin as a biomarker for bevacizumab combination therapies
07/18/2013US20130183303 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
07/18/2013US20130183302 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
07/18/2013US20130183301 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer
07/18/2013US20130183300 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
07/18/2013US20130183278 Method for diagnosis
07/18/2013US20130183248 Method and kit for detection of autoimmune chronic urticaria
07/18/2013US20130183243 Methods and Device for Tuning Multiplexed Markers for Disease Assay
07/18/2013US20130182922 Interactive and automated tissue image analysis with global training database and variable-abstraction processing in cytological specimen classification and laser capture microdissection applications
07/18/2013US20130180868 Test method for the ketone number of an animal specimen
07/18/2013US20130180510 Non-intrusive exhaust gas sensor monitoring
07/18/2013US20130180509 Non-intrusive exhaust gas sensor monitoring
07/18/2013DE112011102090T5 Nanofluidische Feldeffekteinheit zum Steuern des DNS-Transports durch einen Nanokanal der einen Satz von Elektroden aufweist Has nanofluidic field effect unit for controlling the DNA transport through a nanochannel of a set of electrodes
07/18/2013DE112010005878T5 Verfahren zur Prüfung der Hygroskopizität von Tabaken Method for testing the hygroscopicity of tobacco
07/18/2013DE10258333B4 Metallpartikelsensor Metal particle sensor
07/18/2013DE102013100494A1 Separating paramagnetic material from drop, comprises moving drops containing paramagnetic material in microfluidic channel, attaching electromagnet in vicinity of microfluidic channel, and applying electric current to coil at specific time
07/18/2013DE102012100115B4 Gasgemischerkennungsmodul für Flüssiggas für Kraftfahrzeuge und zugehöriges Verfahren Gas mixture recognition module for liquid gas for motor vehicles and associated method
07/18/2013DE102010022929B4 Verfahren zum Herstellen einer Bilipidschicht sowie Mikrostruktur und Messanordnung A method of manufacturing a microstructure and Bilipidschicht and measuring arrangement
07/18/2013DE102009048811B4 Biosensorvorrichtung mit Selbsttesteinrichtung Biosensor with self-test device
07/18/2013DE10112450B4 Verfahren zur Bestimmung des Gehalts brennbarer Begleitgase Method for determining the content of combustible residual gases
07/18/2013CA2860835A1 Methods of stabilizing total organic carbon (toc) levels in non-acidified standards for toc analyzers at room temperature
07/18/2013CA2857522A1 Immunoassay test slide
07/18/2013CA2827506A1 Bap1 mutational analysis in determining susceptibility to, prognosis of, and treatment of melanocytic neoplasia
07/18/2013CA2826770A1 Characterization of blood hemostasis and oxygen transport parameters
07/18/2013CA2823729A1 Devices, systems and methods for evaluation of hemostasis
07/17/2013EP2615463A2 Apparatus for separating fine particles using magnetophoresis, and method for separating fine particles using same
07/17/2013EP2615462A1 Instrument and method for the automated thermal treatment of liquid samples
07/17/2013EP2615461A1 Method for predicting a risk of increased mortality
07/17/2013EP2615460A1 Imaging and evaluating embryos, oocytes, and stem cells
07/17/2013EP2615459A1 proSP-B based diagnosis of distal airway involvement in asthma
07/17/2013EP2615458A1 Method for diagnosing alzheimer's disease using blood-soluble gpvi
07/17/2013EP2615457A1 Reagent composition for nucleic acid chromatography or immunochromatography, method for measurement by nucleic acid chromatography or immunochromatography, and kit for measurement by nucleic acid chromatography or immunochromatography
07/17/2013EP2615456A1 Method for identifying compounds which inhibit binding of anthrax protein to LRP5/6 receptors
07/17/2013EP2615455A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species
07/17/2013EP2615454A1 Measuring system for measuring viscoelastic characteristics of a sample liquid and a corresponding method
07/17/2013EP2615453A2 Measurement apparatus
07/17/2013EP2615444A1 Method and device for determining the state of degradation of a lubricant oil
07/17/2013EP2615125A1 Nanoporous detectors of monocyclic aromatic compounds and other pollutants
07/17/2013EP2615111A1 Method to identify ligands for sigma-1 receptors
07/17/2013EP2615110A1 Biomarker for diagnosing cancer and method of isolating cancer cell using the same
07/17/2013EP2615103A1 Method for detecting adenocorticotropic hormone and absorbent
07/17/2013EP2614839A2 Method for using BOC/CDO to modulate hedgehog signaling
07/17/2013EP2614376A2 Methods, apparatuses and systems for collection of tissue sections
07/17/2013EP2614375A2 Combination methods of diagnosing cancer in a patient
07/17/2013EP2614374A2 Methods and kits for the detection of an infection in subjects with low specific antibody levels
07/17/2013EP2614373A2 Biomarker signatures and uses thereof
07/17/2013EP2614372A2 Kit for monitoring, detecting and staging gvhd
07/17/2013EP2614371A1 Method for labeling of compounds
07/17/2013EP2614370A1 Prognostic test of the progression of a solid tumour by image analysis
07/17/2013EP2614369A2 Inhibitors of human ezh2, and methods of use thereof
07/17/2013EP2614368A1 Adjustment of a textile measuring device
07/17/2013EP2614365A1 A method and a device for attracting magnetic particles to a surface
07/17/2013EP2614361A1 Phosphorescent based gas safety monitor with phase shift detection
07/17/2013EP2614281A1 Diagnostic method for poppet valves and measuring device for carrying out said method
07/17/2013EP2614161A1 Variant annotation, analysis and selection tool
07/17/2013EP2614160A2 Detection of rna-interacting regions in dna
07/17/2013EP2614159A2 Size selection of dna for chromatin analysis
07/17/2013EP2614156A2 Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme
07/17/2013EP2614086A1 Methods for assessing and identifying or evolving conditionally active therapeutic proteins
07/17/2013EP2614060A2 2-(r2-thio)-10-[3-(4-r1-piperazin-1-yl)propyl]-10h-phenothiazine for treating a beta-amyloidopathy or an alpha-synucleopathy, and method for the diagnosis or prediagnosis thereof
07/17/2013EP2614059A2 Methods for assaying enzyme activities
07/17/2013EP2613866A1 Volatile compounds trap desorption device and method for desorbing volatile compounds from a trap
07/17/2013EP2613800A1 Maturation of gastrointestinal tract
07/17/2013EP2613785A1 Heteroarylmethyl amides
07/17/2013EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
07/17/2013CN203071482U High-tension switchgear having gas analysis function
07/17/2013CN203071425U High-tension switchgear having self-checking function
07/17/2013CN203069607U Western blot automatic detection device
07/17/2013CN203069603U Colloidal gold test strip for detecting betamethasone residue
07/17/2013CN203069602U Immune coupler
07/17/2013CN203069601U Lipoprotein a assay kit
07/17/2013CN203069600U Homocysteine assay kit
07/17/2013CN203069599U Western blot automatic interpretation and analysis device
07/17/2013CN203069598U Semi-quantitative detection progesterone colloidal gold test strip
07/17/2013CN203069597U Colloidal gold test strip for detecting dibutyl phthalate
07/17/2013CN203069596U Flumequine detection kit
07/17/2013CN203069595U Sulfadimethoxine detection kit
07/17/2013CN203069594U Colloidal gold test strip for detecting erythrocin
07/17/2013CN203069593U Test strip for detecting spectinomycin, streptomycin, gentamicin and neomycin
07/17/2013CN203069592U Test strip for detecting spiramycin, streptomycin, gentamicin and neomycin
07/17/2013CN203069591U Multi-item synchronous adjustable immunofiltration device
07/17/2013CN203069590U Loureirin B ELISA (Enzyme-Linked Immuno Sorbent Assay) kit
07/17/2013CN203069589U Loureirin A ELISA (Enzyme-Linked Immuno Sorbent Assay) kit
07/17/2013CN203069588U Container for placing detection strip in euzymelinked immunosorbent assay
07/17/2013CN203069587U Folding type urine detection test paper box
07/17/2013CN203069586U Pull-out urine detection test paper box
07/17/2013CN203069585U Testing batten